Your browser doesn't support javascript.
loading
Pembrolizumab as maintenance therapy for malignant rhabdoid tumor.
Offenbacher, Rachel; Fabish, Lara; Oliver-Krasinski, Jennifer; Loeb, David M; Baker, Alissa.
Affiliation
  • Offenbacher R; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Fabish L; Division of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York, USA.
  • Oliver-Krasinski J; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Loeb DM; Division of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York, USA.
  • Baker A; Department of Pathology, Montefiore Medical Center, Bronx, New York, USA.
Pediatr Blood Cancer ; 69(10): e29660, 2022 10.
Article in En | MEDLINE | ID: mdl-35278029
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdoid Tumor Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdoid Tumor Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Type: Article Affiliation country: United States